166 related articles for article (PubMed ID: 28928439)
41. Interaction Between Polymorphisms of IFN-γ and MICA Correlated with Hepatocellular Carcinoma.
Li H; Liu F; Zhu H; Zhou X; Lu J; Chang H; Hu J
Med Sci Monit; 2016 Feb; 22():549-53. PubMed ID: 26893439
[TBL] [Abstract][Full Text] [Related]
42. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
43. Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data.
Trépo E; Nahon P; Bontempi G; Valenti L; Falleti E; Nischalke HD; Hamza S; Corradini SG; Burza MA; Guyot E; Donati B; Spengler U; Hillon P; Toniutto P; Henrion J; Franchimont D; Devière J; Mathurin P; Moreno C; Romeo S; Deltenre P
Hepatology; 2014 Jun; 59(6):2170-7. PubMed ID: 24114809
[TBL] [Abstract][Full Text] [Related]
44. Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.
Miki D; Ochi H; Hayes CN; Abe H; Yoshima T; Aikata H; Ikeda K; Kumada H; Toyota J; Morizono T; Tsunoda T; Kubo M; Nakamura Y; Kamatani N; Chayama K
Nat Genet; 2011 Jul; 43(8):797-800. PubMed ID: 21725309
[TBL] [Abstract][Full Text] [Related]
45. The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.
Ezzikouri S; Alaoui R; Tazi S; Nadir S; Elmdaghri N; Pineau P; Benjelloun S
Infect Genet Evol; 2014 Jan; 21():179-83. PubMed ID: 24269995
[TBL] [Abstract][Full Text] [Related]
46. MICA SNPs and the NKG2D system in virus-induced HCC.
Goto K; Kato N
J Gastroenterol; 2015 Mar; 50(3):261-72. PubMed ID: 25270965
[TBL] [Abstract][Full Text] [Related]
47. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
48. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
[TBL] [Abstract][Full Text] [Related]
49. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
50. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
51. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
53. miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with
Youssef SS; Youness RA; Abbas EAE; Osman NM; ELFiky A; El-Kassas M
Per Med; 2022 Nov; 19(6):483-493. PubMed ID: 36239555
[TBL] [Abstract][Full Text] [Related]
54. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C.
Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C.
Simili A; Mazzella G; Ravaioli F; Festi D; Bacchi-Reggiani ML; Porro A; Bazzoli F; Azzaroli F
J Gastrointestin Liver Dis; 2019 Dec; 28(4):449-456. PubMed ID: 31826071
[TBL] [Abstract][Full Text] [Related]
56. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Cirillo G; Grandone A; Salpietro S; Minichini C; Del Giudice EM; Lazzarin A; Sagnelli E; Coppola N
Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136
[TBL] [Abstract][Full Text] [Related]
57. Neither MICA Nor DEPDC5 Genetic Polymorphisms Correlate with Hepatocellular Carcinoma Recurrence following Hepatectomy.
Motomura T; Ono Y; Shirabe K; Fukuhara T; Konishi H; Mano Y; Toshima T; Yoshiya S; Muto J; Ikegami T; Yoshizumi T; Maehara Y
HPB Surg; 2012; 2012():185496. PubMed ID: 23132957
[TBL] [Abstract][Full Text] [Related]
58. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
59. The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
Scheiner B; Mandorfer M; Schwabl P; Payer BA; Bucsics T; Bota S; Aichelburg MC; Grabmeier-Pfistershammer K; Stättermayer A; Ferenci P; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2015; 10(11):e0143429. PubMed ID: 26599080
[TBL] [Abstract][Full Text] [Related]
60. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
